RSS

drug development

Site management organisation Penta ID Innovation and contract research organisation (CRO) Cromsource have announced a partnership to help improve paediatric drug development. Read more

News

CytoReason has entered into a collaboration agreement with Pfizer over its machine learning model for drug discovery. Read more

News

A collaboration between biopharmaceuticals company Parexel and Microsoft is using mobile and wearable technology to help improve data access within drug development. Read more

Technology

Researchers at the University of Luxembourg have discovered a molecular mechanism giving them a better understanding of how colon cancer develops and progresses, which could aid in the development of treatments to inhibit tumour growth. Read more

News

Provider of label-free drug discovery solutions, SAMDI Tech, has joined forces with a provider of products and services that accelerate research and drug development efforts, Charles River Laboratories, to maximise its clients’ opportunities Read more

News

According to a new study, led by the University of Eastern Finland, there is much more variation in cancer-causing KRAS mutations than originally believed. Read more

News

Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. Read more

News

New innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch and inclusion on payer formularies, according to a new report released by the Economist Intelligence Unit and commissioned by PAREXEL Read more

News

Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has revealed its expansion into its UK-based drug development and clinical trial manufacturing facilities. Read more

News

In this online exclusive, Brady Haggstrom, IDBS, looks at the changing landscape of drug development and delivery, which is more and more outsourced nowadays, and how technology can help protect sensitive research data. Read more

Opinion

Global life sciences company, LabCorp, has acquired scientific process outsourcing company, Sciformix — which will become a part of Covance, LabCorp’s drug development business. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

In this online exclusive, Graham Francis, product marketing manager at Kallik, explains how data integrity should be a top priority when using new technologies in the pharmaceutical industry. Read more

Opinion

In this online exclusive, Dr Andrew Rut, CEO of MyMeds&Me, discusses the value of big data for the pharma industry and the conflict that arises between protecting personal data and effective drug development Read more

Opinion

Clinical-stage drug development company, Evgen Pharma, has been granted a key European patent ascribing intellectual property rights to the company for a method of stabilising sulforaphane, which is the basis of its lead product, SFX-01 Read more

Technology

STA Pharmaceuticals (a subsidiary of WuXi AppTec) has signed an investment agreement with the government of Shanghai, Jinshan District to build a new R&D centre, aimed at strengthening the company’s pharma development and manufacturing platform. Read more

News

Catalent Pharma Solutions has revealed its plans to invest $5 million in the creation of a new drug development centre of excellence (CoE) at its Somerset, New Jersey facility and headquarters Read more

News

Dr Andrew Rut, CEO and founder of MyMeds&Me, examines the critical role of new technology, in the form of smart pharmaceuticals and blockchain, in advancing patient autonomy and drug development. Read more

Opinion

NDA Group, European drug development consultancy, has opened a new office in Paris, France, to serve its growing customer base in the country and continue its global expansion. Read more

A co-founder of the company ApconiX, based in Alderley Park, has revealed his view that attitude towards safety in pre-clinical cancer drug development needs to change. Read more

Opinion